We are live on
!
Find out more
XT
XTX Topco Portfolio holdings
AUM
$5.75B
1-Year Est. Return
30.56%
This Fund
S&P 500
This Quarter
Est. Return
+0.17%
1 Year Est. Return
+30.56%
3 Year Est. Return
+70.38%
5 Year Est. Return
+43.83%
10 Year Est. Return
–
AUM
$3.81B
AUM Growth
+$1.88B
(+98%)
Cap. Flow
+$1.94B
Cap. Flow
% of AUM
50.99%
Top 10 Holdings %
Top 10 Hldgs %
5.52%
Holding
3,983
New
1,493
Increased
1,108
Reduced
652
Closed
727
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$25.6M |
| 2 |
JPMorgan Chase
JPM
|
+$21.7M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$19.7M |
| 4 |
Kroger
KR
|
+$17.9M |
| 5 |
T-Mobile US
TMUS
|
+$15.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$11.3M |
| 2 |
Thermo Fisher Scientific
TMO
|
+$8.42M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$8.34M |
| 4 |
Cisco
CSCO
|
+$8.02M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$8.01M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.84% |
| 2 | Technology | 16.54% |
| 3 | Industrials | 11.45% |
| 4 | Healthcare | 11.32% |
| 5 | Consumer Discretionary | 9.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BOLD
2851
Boundless Bio
BOLD
$55.5M
| $47.5K | ﹤0.01% |
39,577
+10,496
| +36% | +$13.1K |
|
|
CMBM
2852
DELISTED
Cambium Networks
CMBM
| $47.2K | ﹤0.01% |
32,810
+9,056
| +38% | +$15.4K |
|
|
SLAI
2853
DELISTED
SOLAI Ltd ADS
SLAI
| $46.9K | ﹤0.01% |
9,988
+7,449
| +293% | +$96K |
|
2854
Mega Matrix
MPU
$16.4M
| $46.8K | ﹤0.01% |
51,374
+36,958
| +256% | +$41K |
|
|
NEUP
2855
Neuphoria Therapeutics
NEUP
$20.6M
| $46.6K | ﹤0.01% |
+12,008
| New | +$85.3K |
|
|
GRML
2856
Greenland Mines Ltd
GRML
$29.9M
| $46.4K | ﹤0.01% |
160,569
+80,768
| +101% | +$38.7K |
|
|
AXG
2857
Solowin Holdings
AXG
$583M
| $46K | ﹤0.01% |
+11,188
| New | +$40K |
|
2858
VYNE Therapeutics
VYNE
$19.1M
| $45.9K | ﹤0.01% |
+1,581
| New | +$31.7K |
|
|
RVPH
2859
DELISTED
REVIVA PHARMA HLDGS INC
RVPH
| $45.8K | ﹤0.01% |
8,215
+3,195
| +64% | +$35.5K |
|
|
PLG
2860
Platinum Group Metals
PLG
$159M
| $45.7K | ﹤0.01% |
19,368
-95,155
| -83% | -$230K |
|
2861
MMTec
MTC
$328M
| $45.3K | ﹤0.01% |
13,231
+235
| +2% | +$465 |
|
|
MVO
2862
DELISTED
MV Oil Trust
MVO
| $45.1K | ﹤0.01% |
+36,352
| New | +$119K |
|
2863
Wetouch Technology
WETH
$15.5M
| $44.9K | ﹤0.01% |
33,537
+13,117
| +64% | +$25.4K |
|
2864
Airgain
AIRG
$71.9M
| $44.1K | ﹤0.01% |
+10,851
| New | +$44K |
|
2865
Vince Holding Corp
VNCE
$77.6M
| $44K | ﹤0.01% |
+10,776
| New | +$33.1K |
|
2866
Quest Resource Holding
QRHC
$28.3M
| $43.8K | ﹤0.01% |
23,548
-9,435
| -29% | -$16K |
|
2867
SelectQuote
SLQT
$132M
| $43.7K | ﹤0.01% |
+31,011
| New | +$51.9K |
|
2868
Laird Superfood
LSF
$46.8M
| $43.7K | ﹤0.01% |
19,691
+8,209
| +71% | +$29.6K |
|
|
NVNI
2869
Nvni Group
NVNI
$12.7M
| $43.6K | ﹤0.01% |
16,466
+10,382
| +171% | +$35.1K |
|
2870
Enlivex Ltd
ENLV
$37.7M
| $43.5K | ﹤0.01% |
4,120
+1,275
| +45% | +$19K |
|
2871
PodcastOne
PODC
$115M
| $43.4K | ﹤0.01% |
17,567
-2,870
| -14% | -$6.04K |
|
2872
TTEC Holdings
TTEC
$119M
| $43.1K | ﹤0.01% |
+11,979
| New | +$40.7K |
|
2873
Rackspace Technology
RXT
$967M
| $42.9K | ﹤0.01% |
44,189
-85,096
| -66% | -$107K |
|
2874
Grupo Aval
AVAL
$5.79B
| $42.8K | ﹤0.01% |
10,557
-7,462
| -41% | -$30K |
|
2875
Atlas Lithium Corp
ATLX
$79.3M
| $42.5K | ﹤0.01% |
10,042
-16,595
| -62% | -$83.6K |
|
Similar funds
HW
AAM
RWM
SAM
PP
VH
TSW
KIM
XTX Topco's Q4 2025 Portfolio in Review
As of Q4 2025, XTX Topco held 3,983 positions worth $3.81B, up 98% from $1.93B the previous quarter. Its ten largest holdings account for 5.5% of the portfolio.
XTX Topco deployed $1.94B of net new capital in Q4 2025, opening 1,493 new positions and adding to 1,108 existing holdings. Its largest new stake was T-Mobile US: 74,738 shares worth $15.2M.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 14% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $8.34M trimmed.
- XTX Topco's largest Q4 2025 buy was T-Mobile US: 74,738 shares worth $15.2M.
- XTX Topco added most to Procter & Gamble in Q4 2025, an estimated $25.6M increase.
- XTX Topco's biggest Q4 2025 reduction was Bristol-Myers Squibb, cutting an estimated $8.34M.
- XTX Topco fully exited Johnson & Johnson in Q4 2025, selling an estimated $11.3M.
- XTX Topco's ten largest holdings make up 5.5% of its $3.81B portfolio in Q4 2025.
- XTX Topco opened 1,493 new positions and closed 727 in Q4 2025.
- XTX Topco's portfolio value rose 98% quarter-over-quarter to $3.81B.
Based on XTX Topco's 13F filing for Q4 2025, filed 17 Feb 2026.